Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Nivolumab Psa'

Nivolumab Psa published presentations and documents on DocSlides.

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • karlyn-bohler
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

David R.

David R.

  • alida-meadow
  • 47 Slides

Gandara. , MD. University of California, Davis . ...

Integration of Immunotherapy Across

Integration of Immunotherapy Across

  • pamella-moone
  • 51 Slides

the Spectrum of Lung Cancer. Karen Kelly, MD. Pro...

Italian cohort of

Italian cohort of

  • test
  • 3 Slides

nivolumab. Expanded Access . Programme. (EAP): ...

Symptom Management of Novel Agents

Symptom Management of Novel Agents

  • yoshiko-marsland
  • 43 Slides

Amanda Dean, MSN, ACNP-BC, RNFA. Director of Adva...

Precision Medicine

Precision Medicine

  • trish-goza
  • 17 Slides

From Promise to Practice. PRECISION ONCOLOGY IS T...

James L. Gulley M.D. , Ph.D.,

James L. Gulley M.D. , Ph.D.,

  • tatyana-admore
  • 0 Slides

F.A.C.P. .. Head, Immunotherapy Section. Chief, G...

Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) fo

Overall survival and safety experience from an expanded access program (EAP) of nivolumab (NIVO) fo

  • olivia-moreira
  • 0 Slides

Milton Barros e Silva,. 1. Rafael Schmerling,. 2...

Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

  • myesha-ticknor
  • 0 Slides

Program Goals. Incidence of RCC in the United Sta...

Case Discussion A 52-year-old man initially presented with

Case Discussion A 52-year-old man initially presented with

  • lois-ondreau
  • 0 Slides

nonmuscle. -invasive . bladder cancer. He receive...

Raising the Bar in the Management of Advanced/Metastatic NSCLC

Raising the Bar in the Management of Advanced/Metastatic NSCLC

  • debby-jeon
  • 0 Slides

Dr Tan . Jiunn. Liang. Clinical Specialist (Resp...

Discussion Outline Cells of the Immune System

Discussion Outline Cells of the Immune System

  • lois-ondreau
  • 0 Slides

Innate Immunity. Receptors on T and B Cells Are S...

Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in

Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in

  • yoshiko-marsland
  • 0 Slides

Pan Tumors. This program will include a discussio...

Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have?

Expanding Treatment Options in SCCHN: What Role Do Cancer Immunotherapies Have?

  • marina-yarberry
  • 25 Slides

Expanding Treatment Options in SCCHN: What Role D...

Please note, these are the actual video-recorded

Please note, these are the actual video-recorded

  • min-jolicoeur
  • 67 Slides

proceedings from the live CME event and may inclu...

Immuno-Oncology Dr. Michael Palumbo

Immuno-Oncology Dr. Michael Palumbo

  • mofferro
  • 38 Slides

April 18, 2018. Immuno-Oncology. Activating the im...

Nouveautés dans le CBNPC métastatique

Nouveautés dans le CBNPC métastatique

  • vizettan
  • 98 Slides

Celine Mascaux, MD, . PhD. Multidisciplinary . Onc...

Please note, these are the

Please note, these are the

  • robaut
  • 21 Slides

actual. . video-recorded proceedings from the . l...

Please note, these are the

Please note, these are the

  • vizettan
  • 84 Slides

actual. . video-recorded proceedings from the . l...

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

NA_00092076/ J1414, Protocol Version 4.8 Dated 13November2018

  • singh
  • 95 Slides

1 Study Title: Neoadjuvant Nivolumab, or Nivoluma...

Please refer to CCMB Formulary for Crit

Please refer to CCMB Formulary for Crit

  • patricia
  • 3 Slides

ADULT Updated: October 2 8 , 20 20 eria for Use Pa...

Please refer to CCMB Formulary for Criteria for Use

Please refer to CCMB Formulary for Criteria for Use

  • joanne
  • 2 Slides

ADULTUpdated November 122019Page 1of 2Regimen Refe...

Nivolumab and

Nivolumab and

  • carla
  • 10 Slides

ipilimumab/-UV1 vaccination as 2ndline treatment i...

EDDOP Program Update with EDDOP Accrual P30 Supplement Awardees

EDDOP Program Update with EDDOP Accrual P30 Supplement Awardees

  • delcy
  • 16 Slides

Jeff Moscow, M.D. Investigational Drug Branch, CTE...

Liver tumours Best of ILC 2019

Liver tumours Best of ILC 2019

  • mackenzie
  • 28 Slides

About these slides. These slides provide highlight...

Immuno-Oncology Applications

Immuno-Oncology Applications

  • joy
  • 22 Slides

Lee S. Schwartzberg,. MD, FACP. West Clinic, P.C....

YIR On Demand Lung Benjamin Levy, MD 

YIR On Demand Lung Benjamin Levy, MD 

  • jovita
  • 84 Slides

Assistant Professor. Johns Hopkins School of Medic...

GI CONNECT MEETING SUMMARY

GI CONNECT MEETING SUMMARY

  • hanah
  • 32 Slides

upper . gi. cancer HIGHLIGHTS . FROM ESMO 2022. D...

Checkpoint inhibitors for

Checkpoint inhibitors for

  • paisley
  • 53 Slides

NSCLC. An update. Solange Peters, MD-PhD. Oncology...

Nivolumab + Ipilimumab

Nivolumab + Ipilimumab

  • willow
  • 56 Slides

vs . Platinum-Doublet Chemotherapy . as First-line...

Incorporating Immunotherapy in management of HNSCC

Incorporating Immunotherapy in management of HNSCC

  • candy
  • 33 Slides

ندوة أورام الرأس . و. العنق. ...

Phase II studies of Nivolumab

Phase II studies of Nivolumab

  • brianna
  • 5 Slides

in patients with Advanced . Squamous. (SQ) or Non...

Perioperative SACT in lUNg

Perioperative SACT in lUNg

  • van
  • 19 Slides

cancer. Dr Adam Dangoor. University Hospitals Bris...

Copyright © 2024 DocSlides. All Rights Reserved